These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 868907)

  • 41. Aminoglycoside-related nephrotoxicity in the premature newborn.
    Rajchgot P; Prober CG; Soldin S; Perlman M; Good F; Harding E; Klein J; MacLeod S
    Clin Pharmacol Ther; 1984 Mar; 35(3):394-401. PubMed ID: 6365403
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Isepamicin versus amikacin in the treatment of urinary tract infection.
    Sturm W
    J Chemother; 1995 Jun; 7 Suppl 2():149-54. PubMed ID: 8622104
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacokinetics of amikacin for treatment of urinary tract infections in patients with reduced renal function.
    Höffler D; Koeppe P; Demers HG
    J Infect Dis; 1976 Nov; 134 SUPPL():S369-73. PubMed ID: 993628
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Fundamental and clinical studies on amikacin (BB-K8) in complicated urinary tract infections (author's transl)].
    Mita T; Mayumi K; Kataoka N; Ishigami J
    Jpn J Antibiot; 1977 Mar; 30(3):215-22. PubMed ID: 404447
    [No Abstract]   [Full Text] [Related]  

  • 45. [On the therapy of infections of the urinary tract with the broad spectrum antibiotic gentamicin].
    Bauer KM
    Med Welt; 1967 Apr; 14():908-14. PubMed ID: 4967338
    [No Abstract]   [Full Text] [Related]  

  • 46. A review of results of clinical trials with amikacin.
    Gooding PG; Berman E; Lane AZ; Agre K
    J Infect Dis; 1976 Nov; 134 SUPPL():S441-5. PubMed ID: 792360
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Amikacin therapy of patients with multiply antibiotic-resistant Serratia marcescens infections: development of increasing resistance during therapy.
    Craven PC; Jorgensen JH; Kaspar RL; Drutz DJ
    Am J Med; 1977 Jun; 62(6):902-10. PubMed ID: 326046
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical evaluation of amikacin in treatment of infections due to gram-negative aerobic bacilli.
    Mathias RG; Ronald AR; Gurwith MJ; McCullough DW; Stiver HG; Berger J; Cates CY; Fox LM; Lank BA
    J Infect Dis; 1976 Nov; 134 SUPPL():S394-401. PubMed ID: 825590
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A comparison of the pharmacokinetics of amikacin and gentamicin.
    Wise R; Walker JM; Mitchard M
    J Antimicrob Chemother; 1981 Jul; 8 Suppl A():45-9. PubMed ID: 7263565
    [No Abstract]   [Full Text] [Related]  

  • 50. The association of aminoglycoside plasma levels with mortality in patients with gram-negative bacteremia.
    Moore RD; Smith CR; Lietman PS
    J Infect Dis; 1984 Mar; 149(3):443-8. PubMed ID: 6715900
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The use of gentamicin in urinary tract infections with special reference to drug levels in complicated (urological) infections.
    Chisholm GD
    Postgrad Med J; 1974 Nov; 50 Suppl 7():23-31. PubMed ID: 4462090
    [No Abstract]   [Full Text] [Related]  

  • 52. [Clinical efficacy, nephrotoxicity and ototoxicity of amikacin].
    Federspil P; Schindler K; Weich C; Tiesler E; Schätzle W; Ziegler M
    Infection; 1979; 7(2):81-7. PubMed ID: 374277
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Study of the nephrotoxicity of gentamicin in humans].
    Mioli V; Albertazzi A; Scolari P; Bortolotti GC
    G Clin Med; 1971 Oct; 52(10):756-75. PubMed ID: 5152859
    [No Abstract]   [Full Text] [Related]  

  • 54. Amikacin for treatment of infections in patients with malignant diseases.
    Bodey GP; Rodriguez V; Valdivieso M; Feld R
    J Infect Dis; 1976 Nov; 134 SUPPL():S421-7. PubMed ID: 993633
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative clinical studies of ototoxicity and nephrotoxicity of amikacin and gentamicin.
    Lerner SA; Seligsohn R; Matz GJ
    Am J Med; 1977 Jun; 62(6):919-23. PubMed ID: 868906
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [New experience with gentamicin].
    Diez E; Gherardi CR; Mazzei CM; Rechniewski C
    Prensa Med Argent; 1967 Apr; 54(7):321-5. PubMed ID: 5614088
    [No Abstract]   [Full Text] [Related]  

  • 57. Gentamicin in urinary infections of children.
    Holt RJ; Newman RL
    Arch Dis Child; 1968 Jun; 43(229):329-33. PubMed ID: 4871011
    [No Abstract]   [Full Text] [Related]  

  • 58. Amikacin in gram-negative paediatric infections.
    Trujillo H; Manotas R; Ramirez JI; Uribe A; Agudelo N; Zapata CT; Zuluaga AI; de Vidal EL
    J Int Med Res; 1978; 6(4):257-65. PubMed ID: 357227
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Review of 152 patients with bacteremias treated with amikacin.
    Tally FP; Gorbach SL
    Am J Med; 1977 Jun; 62(6):940-4. PubMed ID: 868910
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Experience with intravenous drip infusion of amikacin in urological field (author's transl)].
    Murahashi I; Toyoda A; Takasaki E
    Jpn J Antibiot; 1981 Feb; 34(2):133-9. PubMed ID: 7253190
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.